Attached files

file filename
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 - TRANSCEND SERVICES INCdex321.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) - TRANSCEND SERVICES INCdex311.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 - TRANSCEND SERVICES INCdex322.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) - TRANSCEND SERVICES INCdex312.htm
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q/A

(Amendment No.1)

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2009

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number 000-18217

 

 

TRANSCEND SERVICES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   33-0378756

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S Employer

Identification No.)

One Glenlake Parkway, Suite 1325, Atlanta, GA 30328

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (678) 808-0600

      

 

(Former name, former address, and former fiscal year, if changed since last report)

 

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell Company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of the Registrant’s common stock as of the latest practicable date.

 

Class

 

Outstanding at July 31, 2009

Common Stock, $0.05 par value   8,497,342

 

 

 


Table of Contents

Explanatory Note

Transcend Services, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (“Form 10-Q/A”) to our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2009, initially filed with the Securities and Exchange Commission (the “SEC”) on August 3, 2009 (the “Original Filing”) to amend the certifications in exhibits 31.1 and 31.2.

In the Company’s previously filed 10-Q, some language in the certifications attached as exhibit 31.1 and 31.2 did not conform to the language in Item 601(b)(31)(i) of Regulation S-K.

This Amendment No.1 to Form 10-Q amends exhibits 31.1 and 31.2 only. It does not, and does not purport to, amend, update or restate the information in the Original Filing or reflect any events that have occurred after the Original Filing was made.

 

2


Table of Contents

INDEX

 

          Page
Number

PART I.

   FINANCIAL INFORMATION    4

Item 1.

   Financial Statements (Unaudited)    4
  

Balance Sheets as of June 30, 2009 and December 31, 2008

   4
  

Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2009 and 2008

   5
  

Statement of Stockholders’ Equity for the Six Months Ended June 30, 2009

   6
  

Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2009 and 2008

   7
  

Notes to Consolidated Financial Statements

   8

Item 2

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    13

Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    17

Item 4.

   Controls and Procedures    17

PART II.

   OTHER INFORMATION    17

Item 1.

   Legal Proceedings    17

Item 1A.

   Risk Factors    17

Item 2.

   Unregistered Sales of Equity Securities and Use of Proceeds    17

Item 3.

   Defaults upon Senior Securities    17

Item 4.

   Submission of Matters to a Vote of Security Holders    18

Item 5.

   Other Information    18

Item 6.

   Exhibits    19

SIGNATURES

   20

 

3


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

TRANSCEND SERVICES, INC.

BALANCE SHEETS

(Rounded to the nearest thousand)

 

     June 30,
2009
(unaudited)
    December 31,
2008
 
ASSETS     

Current assets:

    

Cash and cash equivalents

   $ 7,807,000      $ 12,282,000   

Accounts receivable, net of allowance for doubtful accounts of $113,000 and $99,000 at June 30, 2009 and December 31, 2008, respectively

     7,427,000        5,929,000   

Deferred income tax, net

     163,000        288,000   

Prepaid income tax

     848,000        —     

Prepaid expenses and other current assets

     352,000        332,000   
                

Total current assets

     16,597,000        18,831,000   

Property and equipment:

    

Computer equipment

     2,767,000        2,376,000   

Software

     2,818,000        2,794,000   

Furniture and fixtures

     519,000        487,000   
                

Total property and equipment

     6,104,000        5,657,000   

Accumulated depreciation and amortization

     (4,379,000     (3,973,000
                

Property and equipment, net

     1,725,000        1,684,000   

Intangible assets:

    

Goodwill

     10,560,000        4,717,000   

Other intangible assets

     3,099,000        795,000   
                

Total intangible assets

     13,659,000        5,512,000   

Accumulated amortization

     (688,000     (530,000
                

Intangible assets, net

     12,971,000        4,982,000   

Deferred income tax, net

     157,000        519,000   

Other assets

     72,000        79,000   
                

Total assets

   $ 31,522,000      $ 26,095,000   
                
LIABILITIES AND STOCKHOLDERS’ EQUITY     

Current liabilities:

    

Accounts payable

   $ 1,178,000      $ 981,000   

Accrued compensation and benefits

     2,086,000        1,704,000   

Revolving promissory note

     2,000        4,000   

Promissory notes payable

     477,000        477,000   

Other accrued liabilities

     869,000        672,000   
                

Total current liabilities

     4,612,000        3,838,000   

Long term liabilities:

    

Promissory notes payable

     —          238,000   

Other liabilities

     157,000        169,000   
                

Total long term liabilities

     157,000        407,000   

Commitments and contingencies

    

Stockholders’ equity:

    

Preferred stock, $0.01 par value; 2,000,000 shares authorized and no shares outstanding at June 30, 2009 and December 31, 2008

     —          —     

Common stock, $0.05 par value; 15,000,000 shares authorized at June 30, 2009 and December 31, 2008; 8,485,000 and 8,451,000 shares issued and outstanding at June 30, 2009 and December 31, 2008, respectively

     425,000        423,000   

Additional paid-in capital

     32,006,000        30,439,000   

Retained deficit

     (5,678,000     (9,012,000
                

Total stockholders’ equity

     26,753,000        21,850,000   
                

Total liabilities and stockholders’ equity

   $ 31,522,000      $ 26,095,000   
                

The accompanying notes are an integral part of these financial statements.

 

4


Table of Contents

TRANSCEND SERVICES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited and rounded to the nearest thousand,

except earnings per share)

 

     Three months ended
June 30,
   Six months ended
June 30,
     2009    2008    2009    2008

Revenue

   $ 16,966,000    $ 11,973,000    $ 31,896,000    $ 23,702,000

Direct costs

     10,851,000      7,570,000      20,438,000      15,145,000
                           

Gross profit

     6,115,000      4,403,000      11,458,000      8,557,000

Operating expenses:

           

Sales and marketing

     446,000      301,000      853,000      489,000

Research and development

     364,000      266,000      733,000      533,000

General and administrative

     2,174,000      1,434,000      3,940,000      2,771,000

Depreciation and amortization

     309,000      201,000      564,000      397,000
                           

Total operating expenses

     3,293,000      2,202,000      6,090,000      4,190,000
                           

Operating income

     2,822,000      2,201,000      5,368,000      4,367,000

Interest and other expense, net

     30,000      9,000      61,000      16,000
                           

Income before income taxes

     2,792,000      2,192,000      5,307,000      4,351,000

Income tax provision

     1,036,000      757,000      1,973,000      1,556,000
                           

Net income

   $ 1,756,000    $ 1,435,000    $ 3,334,000    $ 2,795,000
                           

Basic earnings per share:

           

Net earnings per share

   $ 0.21    $ 0.17    $ 0.39    $ 0.33
                           

Weighted average shares outstanding

     8,483,000      8,451,000      8,476,000      8,448,000
                           

Diluted earnings per share:

           

Net earnings per share

   $ 0.20    $ 0.16    $ 0.38    $ 0.31
                           

Weighted average shares outstanding

     8,874,000      8,938,000      8,831,000      8,933,000
                           

The accompanying notes are an integral part of these consolidated financial statements.

 

5


Table of Contents

TRANSCEND SERVICES, INC.

STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE SIX MONTHS ENDED JUNE 30, 2009

(Unaudited and rounded to the nearest thousand)

 

     Number of
Shares of
Series A
Preferred
Stock
   Series A
Preferred
Stock
   Number of
Shares of
Common
Stock
   Common
Stock
   Additional
Paid-in
Capital
   Retained
Deficit
    Stockholders’
Equity

Balance, December 31, 2008

   —      $ —      8,451,000    $ 423,000    $ 30,439,000    $ (9,012,000   $ 21,850,000

Net income

                    3,334,000        3,334,000

Issuance of common stock from stock incentive plans

         34,000      2,000      81,000        83,000

Share-based compensation expense

                 258,000        258,000

Tax benefit from disqualifying dispositions of stock options and warrants

                 1,228,000        1,228,000
                                             

Balance, June 30, 2009

   —      $ —      8,485,000    $ 425,000    $ 32,006,000    $ (5,678,000   $ 26,753,000
                                             

The accompanying notes are an integral part of this financial statement.

 

6


Table of Contents

TRANSCEND SERVICES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited and rounded to the nearest thousand)

 

     Six months ended June 30,  
     2009     2008  

Cash flows from operating activities:

    

Net income

   $ 3,334,000      $ 2,795,000   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Deferred income taxes

     487,000        1,370,000   

Depreciation and amortization

     564,000        397,000   

Share-based compensation

     258,000        147,000   

Employment credits – debt forgiveness

     —          (23,000

Changes in assets and liabilities:

    

Accounts receivable, net

     (168,000     479,000   

Prepaid income tax, excluding tax benefit for share-based payments

     380,000        —     

Tax benefit for share-based payments

     (1,228,000     —     

Prepaid expenses and other current assets

     (7,000     (162,000

Other assets

     14,000        44,000   

Accounts payable

     137,000        144,000   

Accrued and other liabilities

     (131,000     (296,000
                

Total adjustments

     306,000        2,100,000   
                

Net cash provided by operating activities

     3,640,000        4,895,000   

Cash flows from investing activities:

    

Capital expenditures

     (372,000     (424,000

Proceeds from disposition of assets

     —          (40,000

Purchase of businesses, net of cash acquired

     (8,814,000     —     
                

Net cash used in investing activities

     (9,186,000     (464,000

Cash flows from financing activities:

    

Proceeds from stock options and other issuances

     83,000        59,000   

Tax benefit for share-based payments

     1,228,000        —     

Repayment of promissory notes payable to related parties

     —          (1,167,000

Repayment of promissory notes payable

     (238,000     (110,000

Repayment of revolving promissory note

     (2,000     —     
                

Net cash provided by (used in) financing activities

     1,071,000        (1,218,000
                

Net change in cash and cash equivalents

     (4,475,000     3,213,000   

Cash and cash equivalents at beginning of period

     12,282,000        4,996,000   
                

Cash and cash equivalents at end of period

   $ 7,807,000      $ 8,209,000   
                

Supplemental cash flow information:

    

Cash paid for interest

   $ 22,000      $ 59,000   

Cash paid for interest to related parties

   $ —        $ 38,000   

Cash paid for income taxes

   $ 1,376,000      $ 185,000   

Non-cash investing and financing activities:

    

Additional contingent consideration accrued for previous acquisition

   $ 475,000      $ 19,000   

The accompanying notes are an integral part of these consolidated financial statements.

 

7


Table of Contents

TRANSCEND SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2009 and 2008

(Unaudited)

1. BASIS OF PRESENTATION

The accompanying financial statements include the accounts of Transcend Services, Inc. (the “Company” or “Transcend”) and for periods prior to May 31, 2008, its wholly-owned subsidiary, Medical Dictation, Inc. (“MDI”). MDI was merged into the Company on May 31, 2008 and all intercompany accounts and transactions have been eliminated in consolidation.

The accompanying consolidated financial statements are unaudited and have been prepared by the management of Transcend in accordance with the rules and regulations of the Securities and Exchange Commission. In the opinion of management, all adjustments, consisting of normal recurring accruals, necessary for the fair presentation of the consolidated financial position, results of operations and cash flows, have been included. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2008. Footnote disclosure that substantially duplicates the disclosure contained in that document has been omitted. Certain items previously reported in specific financial statement captions have been reclassified to conform to this presentation.

2. RECENT ACCOUNTING PRONOUNCEMENTS

Recently Adopted Accounting Pronouncements

In December 2007, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standard (“SFAS”) No. 141(R), Business Combinations. This Statement retains the fundamental requirements in SFAS 141, Business Combinations. However, SFAS 141(R) requires that acquisition costs be recognized separately from the acquisition and also requires the recognition of assets and liabilities assumed arising from contractual contingencies as of the acquisition date. SFAS 141(R) is effective for the fiscal year beginning January 1, 2009. This Statement amends FASB Statement No. 109, Accounting for Income Taxes, to require the acquirer to recognize changes in the amount of its deferred tax benefits that are recognizable because of a business combination either in income from continuing operations in the period of the combination or directly in contributed capital, depending on the circumstances. The Statement also requires that a Company account for the potential tax effects of temporary differences, carry forwards, and any income tax uncertainties of the company acquired that exist at the acquisition date or that arise as a result of the acquisition in accordance with Statement 109, as amended, and related interpretative guidance, including FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes. The Company’s adoption of SFAS 141(R) resulted in the expensing of $118,000 and $182,000 of acquisition costs in the three and six months ended June 30, 2009, respectively, in connection with the two acquisitions discussed in Note 3.

In March 2008, the FASB issued SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities—an Amendment of FASB Statement 133. SFAS 161 requires enhanced disclosures regarding how: (a) an entity uses derivative instruments; (b) derivative instruments and related hedged items are accounted for under FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities; and (c) derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows. SFAS 161 is effective for fiscal years and interim periods beginning after November 15, 2008 with early application being encouraged. The Company does not have any derivative instruments nor is it currently involved in hedging activities and therefore the adoption of SFAS 161 did not have a material impact on the Company’s financial statements.

In April 2008, the FASB issued FASB Staff Position (“FSP”) No. FAS 142-3, which amends the factors that must be considered in developing renewal or extension assumptions used to determine the useful life over which to amortize the cost of a recognized intangible asset under SFAS No. 142, Goodwill and Other Intangible Assets. The FSP requires an entity that is estimating the useful life of a recognized intangible asset to consider its historical experience in renewing or extending similar arrangements or, in the absence of historical experience, must consider assumptions that market participants would use about renewal or extension that are both consistent with the asset’s highest and best use and adjusted for entity-specific factors under SFAS No. 142. The FSP is effective for fiscal years beginning after December 15, 2008, and the guidance for determining the useful life of a recognized intangible asset must be applied prospectively to intangible assets acquired after the effective date. The Company’s adoption of FSP No. FAS 142-3 did not have a material effect on its financial statements.

In May 2008, the FASB issued SFAS No. 162, The Hierarchy of Generally Accepted Accounting Principles. SFAS 162 is intended to improve financial reporting by identifying a consistent framework, or hierarchy, for selecting accounting principles to be used in financial statements that are presented in conformity with U.S. generally accepted accounting principles (GAAP) for nongovernmental entities. SFAS 162 is effective 60 days following the SEC’s approval of the Public Company Accounting Oversight Board amendments to AU Section 411, The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles. The adoption of SFAS 162 did not have a significant impact on the Company’s financial statements.

In April 2009, the FASB issued FSP SFAS 141R-1, Accounting for Assets Acquired and Liabilities Assumed in a Business Combination That Arise from Contingencies. FSP SFAS 141R-1 amends the guidance in SFAS 141R to require that assets acquired

 

8


Table of Contents

TRANSCEND SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

June 30, 2009 and 2008

(Unaudited)

 

and liabilities assumed in a business combination that arise from contingencies be recognized at fair value if fair value can be reasonably estimated. If fair value of such an asset or liability cannot be reasonably estimated, the asset or liability would generally be recognized in accordance with SFAS 5, Accounting for Contingencies, and FASB Interpretation (FIN) No. 14, Reasonable Estimation of the Amount of a Loss. FSP SFAS 141R-1 removes subsequent accounting guidance for assets and liabilities arising from contingencies from SFAS 141R and requires entities to develop a systematic and rational basis for subsequently measuring and accounting for assets and liabilities arising from contingencies. FSP SFAS 141R-1 eliminates the requirement to disclose an estimate of the range of outcomes of recognized contingencies at the acquisition date. For unrecognized contingencies, entities are required to include only the disclosures required by SFAS 5. FSP SFAS 141R-1 also requires that contingent consideration arrangements of an acquiree assumed by the acquirer in a business combination be treated as contingent consideration of the acquirer and should be initially and subsequently measured at fair value in accordance with SFAS 141R. FSP SFAS 141R-1 is effective for assets or liabilities arising from contingencies the Company acquires in business combinations occurring after January 1, 2009. FSP SFAS 141R-1 did not have a material effect on the Company’s financial statements (see note 3).

In April 2009, the FASB issued FSP SFAS 107-1 and APB 28-1, Interim Disclosures about Fair Value of Financial Instruments. FSP SFAS 107-1 and APB 28-1 amend SFAS 107, Disclosures about Fair Value of Financial Instruments, to require an entity to provide disclosures about fair value of financial instruments in interim financial information and amend Accounting Principles Board (APB) Opinion No. 28, Interim Financial Reporting, to require those disclosures in summarized financial information at interim reporting periods. Under FSP SFAS 107-1 and APB 28-1, a publicly traded company shall include disclosures about the fair value of its financial instruments whenever it issues summarized financial information for interim reporting periods. In addition, entities must disclose, in the body or in the accompanying notes of its summarized financial information for interim reporting periods and in its financial statements for annual reporting periods, the fair value of all financial instruments for which it is practicable to estimate that value, whether recognized or not recognized in the statement of financial position, as required by SFAS 107. This FSP is effective for interim reporting periods ending after June 15, 2009. The Company has included this disclosure in this filing (see note 6).

In April 2009, the FASB issued FSP SFAS 157-4, Determining Fair Value When the Volume and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly. FSP SFAS 157-4 affirms that the objective of fair value when the market for an asset is not active is the price that would be received to sell the asset in an orderly transaction, and clarifies and includes additional factors for determining whether there has been a significant decrease in market activity for an asset when the market for that asset is not active. FSP SFAS 157-4 requires an entity to base its conclusion about whether a transaction was not orderly on the weight of the evidence. FSP SFAS 157-4 also amended SFAS 157, Fair Value Measurements, to expand certain disclosure requirements. This FSP is effective for interim and annual reporting periods ending after June 15, 2009, and shall be applied prospectively. Adoption of this FSP SFAS 157-4 did not have a material impact on the Company’s financial statements.

In May 2009, the FASB issued SFAS 165, Subsequent Events. SFAS 165 provides guidance on management’s assessment of subsequent events. SFAS 165 clarifies that management must evaluate, as of each reporting period, events or transactions that occur after the balance sheet date “through the date that the financial statements are issued or are available to be issued”. Management must perform its assessment for both interim and annual financial reporting periods and disclose the date through which an entity has evaluated subsequent events and the basis for that date. SFAS 165 is effective for interim and annual periods ending after June 15, 2009. The Company has included this disclosure in this filing (see note 11).

Recently Issued Accounting Pronouncements Not Yet Adopted

In June 2009, the FASB issued SFAS 168, The FASB Accounting Standards Codification™ and the Hierarchy of Generally Accepted Accounting Principles. SFAS 168 establishes the FASB Accounting Standards Codification™ (Codification) as the source of authoritative U.S. GAAP recognized by the FASB to be applied by nongovernmental entities. Once the Codification is in effect, all of its content will carry the same level of authority, effectively superseding SFAS 162. SFAS 168 is effective for financial statements issued for interim and annual periods ending after September 15, 2009. Adoption of SFAS 168 is not expected to have a material impact on the Company’s financial statements.

 

9


Table of Contents

TRANSCEND SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

June 30, 2009 and 2008

(Unaudited)

 

3. ACQUISITIONS

On January 1, 2009, the Company completed the acquisition of DeVenture Global Partners, Inc. (“DeVenture”) in accordance with the Asset Purchase Agreement entered into on December 26, 2008.

Transcend purchased substantially all of the assets and assumed certain liabilities of DeVenture to expand the Company’s market share, capitalize on the potential for the acquired business to grow and leverage Transcend’s fixed overhead costs across a larger revenue base. DeVenture’s debt was not assumed. The fixed purchase price was $4,250,000. Under the terms of the asset purchase agreement, Transcend paid $3,450,000 in cash at closing. The Company established a $400,000 escrow payable to seller upon seller’s delivery of reviewed financial statements and final working capital as of December 31, 2008. In April 2009, this escrow, plus a $64,223 working capital adjustment, was paid to the seller. A second escrow in the amount of $400,000 was established at closing, payable one year after the closing date pending satisfaction of the seller’s representations and warranties. In addition, Transcend paid an earn-out of $60,413 subsequent to June 30, 2009 which was equal to twenty percent of the amount that DeVenture’s annualized revenue for the six-month period after closing exceeded its revenue for the ninety day period prior to closing. Including the earn-out, the total purchase price would equal $4,374,636 if the second escrow was fully paid. The purchase price was funded using cash on hand.

Transcend allocated the purchase price between goodwill, customer relationships, covenants not to compete, property and equipment and working capital. All goodwill and intangible asset amortization related to the acquisition of the DeVenture assets is expected to be deductible for income tax purposes. Transcend has included the results of the DeVenture operations in its financial statements from the closing date forward.

On April 1, 2009, the Company completed the acquisition of the domestic medical transcription business of Transcription Relief Services, Inc. (“TRS”) in accordance with the Asset Purchase Agreement entered into on March 26, 2009. Transcend purchased the TRS assets and assumed certain liabilities of TRS to expand the Company’s market share, capitalize on the potential for the acquired business to grow and leverage Transcend’s fixed overhead costs across a larger revenue base. TRS’s debt was not assumed. The fixed purchase price was $4,500,000. Transcend paid $4,000,000 in cash at closing. In May 2009, Transcend paid an additional amount of $500,000 upon the seller’s delivery of reviewed financial statements and final working capital as of March 31, 2009. A contingent payment, due in 2010, is based on fourth quarter 2009 revenue and sold backlog at December 31, 2009, subject to an overall cap of $3,000,000. Based on the June 30, 2009 forecast for 2009, the Company has estimated the contingent payment to be approximately $350,000, increasing the estimated total purchase price to $4,850,000. The purchase price was funded using cash on hand.

Transcend initially allocated the purchase price between goodwill, customer relationships, covenants not to compete, property and equipment and working capital. All goodwill and intangible asset amortization related to the acquisition of the TRS assets is expected to be deductible for income tax purposes. Transcend has included the results of TRS operations in its financial statements from the close date forward. The Company anticipates finalizing the purchase price allocation by the end of 2009 and does not expect any changes to the purchase price allocation to materially increase or decrease amortization expenses, but they may have a material effect on the amount of recorded goodwill and other intangible assets.

During the quarter ended March 31, 2008, the Company accrued for an additional $39,000 earn-out related to the December 31, 2005 acquisition of PracticeXpert.

4. MAJOR CUSTOMERS

No single customer accounted for greater than 10% of total revenue for the three and six months ended June 30, 2009 and 2008. The Company provides medical transcription services under individual contracts to customers that are members of a group of hospitals. Revenue attributable to members of this group comprised 16% and 21% of the Company’s total revenue for the three months ended June 30, 2009 and 2008, respectively and 18% and 22% of the Company’s total revenue for the six months ended June 30, 2009 and 2008, respectively. The decrease in percent in 2009 from 2008 is due to the addition of DeVenture and TRS customers, none of which are members of this group.

5. GOODWILL AND OTHER INTANGIBLE ASSETS

The Company accounts for goodwill and other intangible assets in accordance with the provisions of SFAS No. 142, Goodwill and Other Intangible Assets. Under the provisions of this Statement, goodwill and intangible assets that have indefinite useful lives are tested at least annually for impairment rather than being amortized like intangible assets with finite useful lives, which are amortized over their useful lives. A portion of the respective purchase prices of the acquisitions of MDI and PracticeXpert in 2005, OTP Technologies, Inc. (“OTP”) in 2007 and DeVenture and TRS in 2009 were attributed to goodwill and other intangible assets.

 

10


Table of Contents

TRANSCEND SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

June 30, 2009 and 2008

(Unaudited)

 

Other Intangible Assets

(Rounded to the nearest thousand)

 

          June 30, 2009
(unaudited)
   December 31, 2008
     Useful Life
in Years
   Gross
Assets
   Accumulated
Amortization
   Net
Assets
   Gross
Assets
   Accumulated
Amortization
   Net
Assets

Amortized intangible assets:

                    

Covenants-not-to-compete

   5    $ 118,000    $ 48,000    $ 70,000    $ 50,000    $ 39,000    $ 11,000

Customer relationships

   5-10      2,981,000      640,000      2,341,000      745,000      491,000      254,000
                                            

Total intangible assets

      $ 3,099,000    $ 688,000    $ 2,411,000    $ 795,000    $ 530,000    $ 265,000
                                            

6. FAIR VALUE OF FINANCIAL INSTRUMENTS

In accordance with SFAS No. 107, Disclosures About Fair Value of Financial Instruments, the carrying value of short-term debt, which totaled $479,000 as of June 30, 2009 and $481,000 as of December 31, 2008, was estimated to approximate its fair value. The carrying value of long-term debt of $0 at June 30, 2009 and $238,000 at December 31, 2008 approximated fair value. The fair value of debt is estimated based on approximate market interest rates for similar issues. The Company’s other financial instruments, including cash and cash equivalents, accounts receivable and accounts payable approximate fair value due to the short-term nature of those assets and liabilities.

7. BORROWING ARRANGEMENTS

Revolving promissory note and term loan

The Company maintains a four year credit facility with Healthcare Finance Group (“HFG”). The HFG facility matures on December 31, 2009 and was initially comprised of up to $3.6 million on an accounts receivable-based revolving promissory note and up to $2.0 million of term loans to fund acquisitions. The term loan portion expired on December 31, 2007. As a part of the agreement with HFG, the Company issued a warrant to HFG to purchase 100,000 shares of Transcend common stock at an exercise price of $2.25 per share. The fair value of the warrant at grant date was estimated to be $74,000 and is being amortized into interest expense over the life of the credit facility. On June 20, 2007 HFG exercised the warrant, receiving 89,008 unregistered shares of Transcend common stock in a cashless exercise. Borrowings bear interest at LIBOR plus 4% (4.31% as of June 30, 2009), are secured by accounts receivable and other Company assets and require that the Company maintain certain financial and other covenants.

The balance outstanding under the revolving promissory note was $2,000 and $4,000 at June 30, 2009 and December 31, 2008, respectively. As of June 30, 2009, $3.6 million was available under the HFG line of credit.

MDI Promissory Note

On January 31, 2005, the Company entered into a three year, $3.5 million promissory note in conjunction with the purchase of MDI. The note was secured by the common stock of MDI and bears interest at 5.0%. The note repayment terms are as follows:

 

   

On January 31, 2006, one-third of the principal payable together with all accrued but unpaid interest.

 

   

On January 31, 2007, one-half of the remaining principal together with all accrued but unpaid interest.

 

   

On January 31, 2008, the remaining principal together with all accrued but unpaid interest.

On August 15, 2005, the holder of the $3.5 million promissory note reduced the principal amount of the note by $100,000 in consideration for 35,971 unregistered shares of Transcend’s common stock issued at $2.78 per share, or 110% of fair market value. On December 26, 2005, the holder of the promissory note reduced the principal amount of the note by an additional $300,000 in consideration for 140,815 unregistered shares of Transcend’s common stock issued at $2.13 per share, or 105% of fair market value. As of December 31, 2007, the balance of the note was $1.2 million, which was subsequently paid with available cash in the first quarter of 2008.

 

11


Table of Contents

TRANSCEND SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

June 30, 2009 and 2008

(Unaudited)

 

DCOA Promissory Note

On April 6, 2005, the Company fulfilled the prerequisites for receiving the proceeds under a promissory note dated March 1, 2005 payable to the Development Corporation of Abilene, Inc. (“DCOA”) in the principal amount of $1.0 million (the “Promissory Note”). Transcend received $850,000 under the Promissory Note on April 7, 2005 and was pre-funded $150,000 under the Promissory Note on March 31, 2005. The Promissory Note was initially secured by a $150,000 letter of credit from a bank and certain furniture and equipment. The letter of credit was released December 7, 2005 and the remaining collateral shall be released as the principal balance of the Promissory Note is reduced.

The Promissory Note relates to the Agreement for Financial Assistance by and between DCOA and Transcend effective as of March 1, 2005 that was approved by DCOA on March 4, 2005 and amended on June 6, 2006 (collectively, the “Agreement”). Under the terms of the Agreement, DCOA agreed to provide up to $2 million of interest-free, secured loans to Transcend (the “Loans”). In return, Transcend established and operated a medical transcription training center and regional office in Abilene, Texas. In addition, Transcend agreed to recruit, hire and train up to 208 medical transcription professionals, the majority of whom shall be recruited from Abilene or the area surrounding Abilene, as defined in the Agreement. DCOA offered the Loans to Transcend in two increments of $1 million each in return for Transcend recruiting, hiring and training up to 104 medical transcription professionals for each Loan. The Promissory Note is the first such Loan. During 2007, the Company was informed by the DCOA that the second $1 million loan was no longer available.

Transcend and DCOA intended for the Promissory Note to be paid by Transcend using quarterly training credits and annual job creation/retention incentive credits provided to Transcend by DCOA as defined in the Agreement. Principal reductions of the Promissory Note effected through quarterly training credits and annual earned job creation incentive credits, not cash, totaled $349,000 through November 30, 2008.

On December 1, 2008, Transcend entered into a new agreement with the DCOA whereby the DCOA reduced the loan principal by $101,000 in exchange for agreement by Transcend to retire the debt three years earlier than agreed and the cancellation of potential future credits earned through training and job creation. In the fourth quarter of 2008, this reduction was booked to direct costs as were previous training and job credits earned. Transcend will pay DCOA six quarterly payments of $92,000 commencing January 1, 2009 with the final payment due April 1, 2010 to satisfy the remaining principal amount. The note will continue to carry a zero percent interest rate. The principal balance on the Promissory Note was $367,000 as of June 30, 2009.

OTP Promissory Note

On January 16, 2007, the Company entered into a three year, $330,000 unsecured promissory note in conjunction with the purchase of OTP. The note bears interest at 5.0% and the principal is to be repaid as follows: $110,000 on January 16, 2008; $55,000 on July 16, 2008; $55,000 on January 16, 2009; $55,000 on July 16, 2009 and $55,000 on January 16, 2010. As of June 30, 2009, the balance of the promissory note was $110,000.

8. TRANSACTIONS WITH RELATED PARTIES

The Company purchased the assets of OTP on January 16, 2007 for a purchase price of $1,070,000, of which $520,000 was payable in cash, $330,000 in a promissory note and $220,000 (60,274 shares) in Transcend unregistered common stock. In addition, Transcend paid $40,000 of additional consideration in January 2008 based on revenue achieved in 2007. The promissory note is payable to OTP. The owners of OTP, James and Sharon Vonderhaar, were employed by the Company until April 1, 2007 and February 5, 2008, respectively.

Susan McGrogan is the Company’s Chief Operating Officer. Ms. McGrogan is also the co-founder of MDI, which was purchased by Transcend on January 31, 2005. In conjunction with the purchase of MDI, the Company entered into a $3.5 million promissory note payable to Ms. McGrogan, the terms of which are described in Note 7, “Borrowing Arrangements.” During the first quarter of 2008, the Company repaid $1.2 million as the final installment on the note plus $59,000 of accrued interest.

9. STOCK-BASED COMPENSATION

The Company has six stockholder-approved stock incentive plans (the “Plans”) for its key employees, directors and key consultants. The Plans provide for the grant of incentive stock options, nonqualified stock options, restricted stock awards, and, in the case of the plans approved by the shareholders on May 10, 2007 and May 19, 2009, restricted stock units and stock appreciation rights. The Company intends to grant new awards under the 2009 stock incentive plan only. The options are granted at fair market value, as defined in the option agreement, on the date of grant. There are 384,924 options available for issuance at June 30, 2009.

 

12


Table of Contents

TRANSCEND SERVICES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

June 30, 2009 and 2008

(Unaudited)

 

On January 1, 2006, the Company adopted, using a modified version of prospective application, SFAS No. 123(R), Share Based Payment (“SFAS 123(R)”). This Statement requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values at the date of grant.

The fair value of each option grant is estimated on the date of grant using the Black-Scholes-Merton option-pricing model. The following assumptions were used for all options granted during the quarter ending June 30, 2009: dividend yield of 0%; volatility of 92.47%; risk-free interest rate of 1.85%; expected forfeiture rate of 50%; a weighted average exercise price of $13.04; and a weighted average expected life of 2.0 years.

Transactions involving Company stock options for the six months ended June 30, 2009 were as follows:

 

     Number of
Shares
Subject to
Stock Options
    Weighted
Average
Exercise Price
   Weighted
Average
Remaining
Contractual
Life
   Aggregate
Intrinsic
Value*

Outstanding at December 31, 2008

   912,267      $ 6.90    7.7 years   

Granted

   30,000      $ 13.04      

Forfeited

   (8,500   $ 12.86      

Exercised

   (31,100   $ 2.66      

Outstanding at June 30, 2009

   902,667      $ 7.20    7.4 years    $ 7,808,070

 

* The aggregate intrinsic value is based on a closing stock price of $15.85 as of June 30, 2009.

The Company recognized equity-based compensation expense under SFAS 123(R) of approximately $147,000 and $258,000 for the three and six months ended June 30, 2009, respectively, and $88,000 and $147,000 for the three and six months ended June 30, 2008, respectively. As of June 30, 2009, the Company had approximately $1,127,000 of future compensation expense which it expects to record in its statements of operations through 2012.

10. INCOME TAXES

The Company determines its periodic income tax provision based upon the current period taxable income and the annual estimated tax rate for the Company adjusted for any change to prior period estimates. The estimated tax rate is revised, if necessary, as of the end of each successive interim period during the fiscal year to the Company’s current annual estimated tax rate.

The Company’s federal net operating loss carryforwards have been fully utilized in 2009.

Transcend’s effective income tax rate was approximately 37% and 35% for the three months ended June 30, 2009 and 2008, respectively, and 37% and 36% for the six months ended June 30, 2009 and 2008 respectively.

11. SUBSEQUENT EVENT

In accordance with SFAS 165, Subsequent Events, the Company evaluated all events or transactions that occurred after June 30, 2009 up through August 3, 2009, the date these financial statements were issued. During this period, no material recognizable subsequent events occurred.

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly report on Form 10-Q contains certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that represent our expectations, anticipations or beliefs about future events, including our operating results, financial condition, liquidity, expenditures, and compliance with legal and regulatory requirements. For this purpose, any statements that are not statements of historical fact may be deemed to be forward-looking statements. These statements involve risks and uncertainties that could cause actual results to differ materially depending on a variety of important factors. Factors that might cause or contribute to such differences include, but are not limited to, competitive pressures, loss of significant customers, the mix of revenue, changes in pricing policies, delays in revenue recognition, lower-than-expected demand for the Company’s products and services, business conditions in the integrated health care delivery network market, general economic conditions, and the risk factors detailed in our periodic, quarterly and annual reports on Forms 8-K, 10-Q and 10-K that we file with the Securities Exchange Commission (“SEC”) from time to time. With respect to such forward-looking statements, we claim protection under the Private Securities Litigation Reform Act of 1995. Our SEC filings are available from us, and also may be examined at public reference facilities maintained by the SEC or, to the extent filed via EDGAR, accessed through the website of the SEC (http://www.sec.gov). In addition, factors that we are not currently aware of could harm our future operating results. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this filing. We undertake no obligation to make any revisions to the forward-looking statements or to reflect events or circumstances after the date of this filing.

 

13


Table of Contents

Overview

Transcend provides medical transcription services to the healthcare industry. The Company utilizes a combination of its proprietary internet-based voice and data distribution technology, third-party speech recognition technology, customer-based technology and domestic home-based and offshore medical language specialists to convert physicians’ voice recordings into electronic documents.

Outlook

The U.S. economy has deteriorated significantly in recent months, stemming primarily from the disruptions in the global credit markets. The healthcare industry is generally considered to be recession resistant, but Transcend’s customers are not immune to the impact of a weak economy. Restricted access to credit could hinder hospitals’ ability to finance growth or ongoing operations. The decrease in the availability of consumer credit and a higher unemployment rate could impact discretionary healthcare spending by consumers. To date, Transcend has not seen any noticeable decrease in patient encounter volume among its customers. If the economy were to further deteriorate, the Company could see deterioration in collection of its accounts receivable. It is also uncertain what effect the credit crisis may have on the security of the U.S. banking system, and specifically the financial institutions where the Company’s cash and cash equivalents are deposited.

Critical Accounting Estimates which are Material to Registrant

A critical accounting estimate meets two criteria: (1) it requires assumptions about highly uncertain matters; and (2) there would be a material effect on the financial statements from either using a different, also reasonable, amount within the range of the estimate in the current period or from reasonably likely period-to-period changes in the estimate. Our critical accounting estimates are as follows:

Goodwill and Intangible Assets. As of June 30, 2009, the Company had goodwill and net intangible assets at carrying amounts of $10,560,000 and $2,411,000, respectively. The total of $12,971,000 represents approximately 41% of total assets as of June 30, 2009. Intangible assets are amortized over their estimated useful lives. If the estimated useful life assumptions are shortened, the Company would record an impairment entry to recognize the change in assumptions.

Management reviews goodwill and intangibles for impairment annually and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. In testing for impairment, management calculates the fair value of the reporting units to which the goodwill and intangibles relate based on the present value of estimated future cash flows. The Company operates in one reporting unit – medical transcription services. The approach utilized is dependent on a number of factors including estimates of future revenues and costs, appropriate discount rates and other variables. Management bases estimates on assumptions that are believed to be reasonable, but which are unpredictable and inherently uncertain. Therefore, future impairments could result if actual results differ from those estimates.

Deferred Tax Assets. As of June 30, 2009, the Company had net deferred tax assets of $320,000. Deferred tax assets represent future tax benefits we expect to realize. Our ability to utilize the deferred tax benefits is dependent upon our ability to generate future taxable income. SFAS 109, Accounting for Income Taxes, requires us to record a valuation allowance against any deferred income tax benefits that we believe may not be realized. The Company estimates future taxable income to determine whether a valuation allowance is needed. Projecting our future taxable income requires us to use significant judgment regarding expected future revenues and expenses. In addition, we must assume that tax laws will not change sufficiently to materially impact the expected tax liability associated with our expected taxable income. Transcend has valuation allowances against net operating loss carryforwards in certain states in which future taxable income in those states may not be sufficient to utilize the net operating loss carryforwards in those states prior to their expiration.

Stock-Based Compensation. Effective January 1, 2006, the Company adopted the provisions of SFAS No. 123R for its stock-based awards. Under SFAS No. 123R, management makes assumptions regarding the Company’s stock volatility and forfeiture rates required using the Black-Sholes-Merton option-pricing model used to calculate option compensation cost.

Three Months Ended June 30, 2009 Compared to Three Months Ended June 30, 2008

Revenue increased $5.0 million, or 42%, to $17.0 million in the quarter ended June 30, 2009 compared to revenue of $12.0 million in the same period in 2008. The $5.0 million increase in revenue is attributable to revenue from new customers of $1.8 million, revenue contributed by the acquisition of TRS of $1.9 million, revenue contributed by the acquisition of Deventure of $1.3 million, and increased revenue from existing customers of $0.2 million, offset by a decrease in revenue of $0.2 million from customers who terminated their contracts since the second quarter of 2008.

 

14


Table of Contents

Direct costs increased $3.3 million, or 43%, to $10.9 million in the quarter ended June 30, 2009 compared to $7.6 million in the same period in 2008. Direct costs include costs attributable to compensation for transcriptionists, fees paid for speech recognition processing, telephone expenses, recruiting, management, customer service, technical support for operations, and implementation of transcription services. Transcription compensation is a variable cost based on lines transcribed or edited multiplied by specified per-line pay rates that vary by individual as well as type of work. Speech recognition processing is a variable cost based on the minutes of dictation processed. All other direct costs referred to above are semi-variable operations infrastructure costs that periodically change in anticipation of or in response to the overall level of production activity.

As a percentage of revenue, direct costs increased to 64% in the quarter ended June 30, 2009 from 63% in the same period of 2008. The increase in costs as a percentage of revenue was due primarily to an increase in semi-variable operations infrastructure costs. The acquisitions of DeVenture and TRS did not have an impact on direct costs as a percent of revenue and variable costs as a percent of revenue remained flat for existing core business. Gross profit increased $1.7 million or 39%, to $6.1 million in the quarter ended June 30, 2009 compared to $4.4 million in the same period in 2008. Gross profit as a percentage of revenue decreased to 36% in the quarter ended June 30, 2009 compared to 37% in the same period in 2008 (see direct costs discussion).

Sales and marketing expenses increased $145,000, or 48%, to $446,000 in the quarter ended June 30, 2009 compared to $301,000 in the same period of 2008. Sales and marketing expenses as a percentage of revenue were 3% in both the quarters ended June 30, 2009 and 2008. The increase in sales and marketing expense was primarily due to an increase in the commission percentage on sales and increased advertising and marketing efforts.

Research and development expenses increased $98,000, or 37%, to $364,000 in the quarter ended June 30, 2009 compared to $266,000 in the same period in 2008. Research and development expenses as a percentage of revenue were 2% in both the quarters ended March 31, 2009 and 2008. The increase was primarily due to an increase in compensation-related expenses and increases in hardware and software maintenance costs related to information technology initiatives.

General and administrative expenses increased $740,000, or 52%, to $2,174,000 in the quarter ended June 30, 2009 compared to $1,434,000 in the same period in 2008. General and administrative expenses for DeVenture and TRS contributed $131,000 and $191,000 of the increase, respectively. Transcend incurred $118,000 of transaction costs related to acquisitions in the second quarter of 2009. The balance of the increase was due primarily to increased contract services, employee benefits costs, and stock-based compensation expense. General and administrative expenses as a percentage of revenue were 13% and 12% in the quarters ended June 30, 2009 and 2008, respectively.

Depreciation and amortization expense was $309,000 in the quarter ended June 30, 2009 compared to $201,000 in the same period in 2008. Amortization of intangible assets resulting from the acquisitions of DeVenture and TRS contributed $51,000 of the increase.

Interest and other expenses increased $21,000 to $30,000 in the quarter ended June 30, 2009 compared to $9,000 in the same period in 2008. The increase is due primarily to lower interest income on cash, related to the recent changes in the credit environment.

The income tax provision increased $279,000 to $1,036,000 for the three months ended June 30, 2009 compared to $757,000 in the same period in 2008. The provision increased primarily due to higher pre-tax income and a higher effective tax rate of 37% for the quarter ended June 30, 2009 compared to 35% for the quarter ended June 30, 2008.

Six Months Ended June 30, 2009 Compared to Six Months Ended June 30, 2008

Revenue increased $8.2 million, or 35%, to $31.9 million in the six months ended June 30, 2009 compared to revenue of $23.7 million in the same period in 2008. The $8.2 million increase in revenue is attributable to revenue from new customers of $3.4 million, revenue contributed by the acquisition of DeVenture of $2.5 million, revenue contributed by the acquisition of TRS of $1.9 million, and increased revenue from existing customers of $0.8 million, offset by a decrease in revenue of $0.4 million from customers who terminated their contracts since the second quarter of 2008.

Direct costs increased $5.3 million, or 35%, to $20.4 million in the six months ended June 30, 2009 compared to $15.1 million in the same period in 2008. Direct costs include costs attributable to compensation for transcriptionists, recruiting, management, customer service, technical support for operations, fees paid for speech recognition processing, telephone expenses and implementation of transcription services. Transcriptionist compensation is a variable cost based on lines transcribed or edited multiplied by specified per-line pay rates that vary by individual as well as type of work. Speech recognition processing is a variable cost based on the minutes of dictation processed. All other direct costs referred to above are semi-variable production infrastructure costs that periodically change in anticipation of or in response to the overall level of production activity.

Direct costs remained at 64% of revenue in the six months ended June 30, 2009 compared to the same period of 2008. Costs as a percentage of revenue remained flat due primarily to higher direct costs as a percentage of revenue for DeVenture and TRS, offset by the cost savings that resulted from the increased use of speech recognition technology integrated into the Company’s BeyondTXT platform and the use of offshore transcription resources.

 

15


Table of Contents

Gross profit increased $2.9 million, or 34%, to $11.5 million in the six months ended June 30, 2009 compared to $8.6 million in the same period in 2008. Gross profit as a percentage of revenue remained at 36% in the six months ended June 30, 2009 compared to the same period in 2008 (see direct costs discussion).

Sales and marketing expenses increased $364,000, or 74%, to $853,000 in the six months ended June 30, 2009, compared to $489,000 in the same period of 2008. Sales and marketing expenses as a percentage of revenue were 3% and 2% in the six months ended June 30, 2009 and 2008, respectively. The size of the sales force increased to 6 employees in 2009 from 4 employees in 2008. The increase in sales and marketing expense is primarily due to increases in compensation and commissions and increased advertising and marketing efforts.

Research and development expenses increased $200,000, or 38%, to $733,000 in the six months ended June 30, 2009 compared to $533,000 in the same period in 2008. Research and development expenses as a percentage of revenue were 2% in both the six-month periods ended June 30, 2009 and 2008. The increase is primarily due to increases in compensation, contract services and hardware and software maintenance costs related to new Information Technology initiatives.

General and administrative expenses increased $1.2 million, or 42%, to $3.9 million in the six months ended June 30, 2009 compared to $2.8 million in the same period in 2008. General and administrative expenses for DeVenture and TRS contributed $254,000 and $191,000 of the increase, respectively. Transcend incurred $182,000 of transaction costs related to acquisitions in 2009. The remaining increase is due primarily to increases in employee related costs, contract services, and stock compensation expense. General and administrative expenses as a percentage of revenue were 12% in both the six-month periods ended June 30, 2009 and 2008.

Depreciation and amortization expense increased $167,000, or 42%, to $564,000 in the six months ended June 30, 2009 compared to $397,000 in the same period in 2008. Amortization of intangible assets resulting from the acquisitions of DeVenture and TRS contributed $78,000 of the increase.

Interest and other expenses increased $45,000, or 281%, to $61,000 in the six months ended June 30, 2009 compared to $16,000 in the same period in 2008. The increase is due primarily to reduced interest income and increased amortization of finance costs, offset partially by a reduction in the amount of debt outstanding.

The income tax provision increased $417,000 to $1,973,000 for the six months ended June 30, 2009 compared to $1,556,000 in the same period in 2008. The provision increased primarily due to higher pre-tax income and a higher effective tax rate of 37% for the six months ended June 30, 2009 compared to 36% for the six months ended June 30, 2008.

Liquidity and Capital Resources

As of June 30, 2009, the Company had cash and cash equivalents of $7.8 million, working capital of $12.0 million, and availability of approximately $3.6 million on its line of credit based on eligible accounts receivable (see Note 7). The Company had $479,000 of debt outstanding as of June 30, 2009.

Cash provided by operating activities was $3.6 million for the six months ended June 30, 2009 compared to $4.9 million for the six months ended June 30, 2008. The decrease was due primarily to changes in tax related items and in working capital, offset by improved profitability before income taxes.

Cash used in investing activities was $9.2 million for the six months ended June 30, 2009, compared to $464,000 for the six months ended June 30, 2008. The outflow in 2009 was due primarily to the acquisitions of DeVenture for $4.3 million and TRS for $4.5 million.

Cash provided by financing activities was $1.1 million for the six months ended June 30, 2009 compared to cash used in financing activities of $1.2 million in the same period in 2008. The cash provided during 2009 consisted of the tax benefit for share-based payments of $1.2 million and the proceeds on the exercise of stock options of $83,000, offset by note repayments of $240,000. In 2008, the outflow consisted of note repayments of $1.3 million, offset by proceeds of $59,000 from the exercise of stock options.

The Company anticipates that cash on hand, together with cash flow from operations should be sufficient for the next twelve months to finance operations, make capital investments in the ordinary course of business, pay contingent amounts related to previous acquisitions, and pay indebtedness when due.

Part of the growth strategy for Transcend is the completion of acquisitions. Management believes that available cash and the HFG credit facility (until expiration on December 31, 2009) together with other acquisition options, such as seller financing, are only sufficient to complete small acquisitions. Additional financing will be required for larger acquisitions. Although to this date, Transcend has not needed to access the equity or credit markets for additional acquisition funding, management has approached them to determine availability of funding and believes, based on current information that the Company can obtain acquisition financing should the need arise. However, there can be no assurance that funding will remain available.

 

16


Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk

The Company had no material exposure to market risk from derivatives or other financial instruments as of June 30, 2009.

 

Item 4. Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported, within the time periods specified in the rules and forms of the Securities and Exchange Commission (“SEC”). Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information we are required to disclose in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management as appropriate to allow timely decisions regarding required disclosure.

Management evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) or 15d-15(e) under the Exchange Act) as of June 30, 2009. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective.

Management believes, however, that a controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all controls are working as designed and that instances of fraud, if any, within a company have been detected.

Changes in Internal Control over Financial Reporting

Internal control over financial reporting consists of control processes designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the Company’s financial statements for external purposes in accordance with generally accepted accounting principles. To the extent that components of the Company’s internal control over financial reporting are included in the Company’s disclosure controls, they are included in the scope of the evaluation by the Company’s principal executive officer and principal financial officer referenced above. The financial operations of the Company’s recent acquisitions of DeVenture and TRS have been substantially, but not fully, integrated into the Company’s internal controls over financial reporting. The Company anticipates that these operations will be fully integrated by the end of 2009. Management evaluated the changes in the Company’s internal control over financial reporting in the first six months of 2009. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that there have been no other changes in the Company’s internal control over financial reporting during the six months ended June 30, 2009 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

Although from time to time the Company is subject to various legal proceedings in the course of conducting business, the Company is not currently a party to any material legal proceeding.

 

Item 1A. Risk Factors

There have been no material changes in the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2008.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

There were no unregistered sales of equity securities during the quarter ended June 30, 2009.

 

Item 3. Defaults upon Senior Securities

None.

 

17


Table of Contents
Item 4. Submission of Matters to a Vote of Security Holders

The Company held its Annual Meeting of Shareholders on May 19, 2009. The stockholders voted on the following proposals and the results of the voting are presented below.

 

  1. To elect a Board of Directors consisting of seven members to hold office until the next annual meeting of stockholders or until their successors are elected and qualified.

 

Nominee

   Votes For    Votes
Withheld

Joseph G. Bleser

   6,028,631    2,086,178

Joseph P. Clayton

   7,640,067    474,742

James D. Edwards

   7,790,288    324,521

Larry G. Gerdes

   7,814,345    300,464

Walter S. Huff Jr.

   7,807,298    307,511

Sidney V. Sack

   7,649,966    464,843

Charles E. Thoele

   7,616,188    498,621

 

  2. To ratify the appointment of Grant Thornton LLP as independent public accountants to audit the accounts of the Company for the year ending December 31, 2009. The stockholders ratified said appointment with 8,103,134 votes FOR, 10,713 votes AGAINST and 962 ABSTAINING.

 

  3. To approve the 2009 Stock Incentive Plan. The stockholders approved said plan with 3,629,603 votes FOR, 2,181,566 votes AGAINST, 2,387 ABSTAINING and 2,301,253 BROKER NON-VOTES.

 

Item 5. Other Information

None.

 

18


Table of Contents
Item 6. Exhibits

The following exhibits are filed with or incorporated by reference into this report.

 

          Incorporation by Reference

Exhibit
Number

  

Exhibit Description

  

Form

  

File No.

  

Exhibit

   

Filing Date

     3.1    Certificate of Incorporation    S-3    333-106446    4.1      June 25, 2003
    3.2    Restated Bylaws    8-K    000-18217    (a)    December 19, 2007
    3.3    Asset Purchase Agreement between Transcend Services, Inc. and DeVenture Global Partners, Inc.    8-K    000-18217    2.0      December 23, 2008
    3.4    Asset Purchase Agreement between Transcend Services, Inc. and Transcription Relief Services, LLC    8-K    000-18217    2.0      March 27, 2009
    3.5    2009 Stock Incentive Plan    S-8    333-160905    4.3      July 30, 2009
  31.1    Certification of Chief Executive Officer of the Registrant Pursuant to Rule 13a-14(a) or Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended           
  31.2    Certification of Chief Financial Officer of the Registrant Pursuant to Rule 13a-14(a) or Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended           
*32.1    Certification of Chief Executive Officer of the Registrant Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002           
*32.2    Certification of Chief Financial Officer of the Registrant Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002           

 

* This certification is furnished to, but not filed with, the Commission. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that the Registrant specifically incorporates it by reference.

The agreements identified in this report as exhibits are between and among the parties to them, and are not for the benefit of any other person. Each agreement speaks as of its date, and the Company does not undertake to update them, unless otherwise required by the terms of the agreement or by law. As permitted, the Company has omitted some disclosure schedules because the Company has concluded that they do not contain information that is material to an investment decision and is not otherwise disclosed in the agreement or this report. Omitted schedules may nevertheless affect the related agreement. The agreements, including the Company’s representations, warranties, and covenants, are subject to qualifications and limitations agreed to by the parties and may be subject to a contractual standard of materiality, and remedies, different from those generally applicable or available to investors and may reflect an allocation of risk between or among the parties to them. Accordingly, the representations, warranties and covenants of the Company contained in the agreements may not constitute strict representation of factual matters or absolute promises of performance. Moreover, the agreements may be subject to differing interpretations by the parties, and a party may, in accordance with the agreement or otherwise, waive or modify the Company’s representations, warranties, or covenants.

 

19


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    TRANSCEND SERVICES, INC.
November 5, 2009     By:   /s/    LARRY G. GERDES        
      Larry G. Gerdes,
      President and Chief Executive Officer
      (Principal Executive Officer)
    By:   /s/    LANCE CORNELL        
      Lance Cornell,
      Chief Financial Officer
      (Principal Financial Officer)

 

20